Brüush Oral Care Receives Additional Delisting Threat Over Audit Committee Non-Compliance
Brüush Oral Care Receives Additional Delisting Threat Over Audit Committee Non-Compliance
This deficiency will be considered by the Hearings Panel (the "Panel") at a hearing that has been scheduled for April 25, 2024 (the "Hearing") to address the Company's other current deficiencies.
聽證小組（“小組”）將在定於2024年4月25日舉行的聽證會（“聽證會”）上考慮這一缺陷，以解決公司當前的其他缺陷。
As previously reported on May 8, 2023, due to the resignation of one of the Company's board members from its Board of Directors and therefore its Audit Committee on April 12, 2023, the Company no longer complied with the Audit Committee Requirements. Pursuant to Listing Rule 5605(c)(4), Nasdaq provided the Company a cure period to regain compliance with the Audit Committee Requirements, which ended on April 12, 2024.
正如先前在2023年5月8日報道的那樣，由於公司的一名董事會成員於2023年4月12日辭去董事會乃至審計委員會的職務，公司不再遵守審計委員會的要求。根據上市規則5605（c）（4），納斯達克爲公司提供了補救期，以恢復對審計委員會要求的遵守，該要求於2024年4月12日結束。
譯文內容由第三人軟體翻譯。